MyPharmacy+

Calcirek Tablet

Manufactured By Rekvina Laboratories Ltd

Salt Synonyms

Rs. 23.97

MRP 25.23

(5% OFF)

Includes all taxes

Package SIZE

strip of 10 tablets

Price may vary depending on the product batch*

100% Authentic
Products

Free
Shipping*

Products
Return Policy

Information about Calcirek Tablet

Uses / Indications:

Introduction:

Calcirek tablet is a combination of CalciumVitamin D3(calcitriol) and minerals like Zinc and Magnesium and it is used as bone joint supplement.Calcium is used to prevent or treat low blood calcium levels in people who do not get enough calcium from their diets.Calcium is important for growth and development of bones. Vitamin D3(calcitriol) that is used in the absorption of calcium in the blood. Vitamin D3 helps in processing of essential minerals in the body like Calcium and Phosphorus. Lack of Vitamin D3 results in bone weakening bone pain and skin diseases. Other minerals like zinc and magnesium are necessary for bone mineralization and bone matrix formation. Calcirek is a nutritional supplement which can be taken by people who have low levels of calcium in their blood. Calcirek is used in elderly people to keep bones healthy and strong and is even effective in Chronic arthritis and Osteoporosis. Use under medical supervision.

Calcirek Tablet

Manufactured By Rekvina Laboratories Ltd

Salt Synonyms

Rs. 23.97

MRP 25.23

Includes all taxes

Package SIZE

Available Substitutes

1-CC Oral Suspension Sugar Free

Azure Pharmaceuticals

1 Tree Co Q 10 Veg Capsule

Saisir Global Technologies Pvt Ltd

1 Tree Omega 3 6 9 Veg Capsule

Saisir Global Technologies Pvt Ltd

1 Tree Sleep Tight Oral Spray Strawberry

Saisir Global Technologies Pvt Ltd

10 AM Vegetable Capsule

Kachhela Medex Pvt Ltd

Uses / Indications:

Introduction:

How to use:

Description:

Benefits:

Safety Advise:

If you miss a dose:

Fact Box:

Primary Use:

Common Side Effects:

Alcohol Interaction:

Pregnancy Interaction:

Lactation Interaction:

Driving Interaction:

Kidney Interaction:

Liver Interaction:

Q&A: